Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01.09.2022 - NEW YORK and SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) - Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated small molecule therapeutics ...

Related Keywords

,Compensation Committee Of Zentali Board Directors ,Zentalis Pharmaceuticals Inc ,Pharmaceuticals Inc ,Nasdaq ,Compensation Committee ,Zentali Board ,Inducement Incentive Award Plan ,Nasdaq Listing Rule ,